Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Gynecologic 1

Conditions

Ovarian Neoplasms 4Sarcoma 2Carcinoma, Ovarian Epithelial 2Testicular Neoplasms 1Testicular Germ Cell Tumor 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1Malignant mesenchymal tumor 1Liposarcoma 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Fibrosarcoma 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Desmoplastic Small Round Cell Tumor 1Chondrosarcoma 1Breast Neoplasms 1

Interventions

Ifosfamide 3Filgrastim 3Doxorubicin 3Radiotherapy 2perifosine 1Vincristine 1Trabectedin 1Temozolomide 1Sunitinib 1Peripheral Blood Stem Cell Transplantation 1Imatinib Mesylate 1Etoposide 1Epirubicin 1Dactinomycin 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hemangiopericytoma, Malignant × Epirubicin × Gynecologic × Clear all
NCT00025441 2013-12-04

Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors

National Cancer Institute (NCI)

Phase 2 Completed
GynecologicSarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Chondrosarcoma, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Ovarian Neoplasms, Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡